|Application ||WB, IHC-P, E|
|Other Accession||Q05423, Q09139|
|Calculated MW||14889 Da|
|Antigen Region||104-132 aa|
|Other Names||Fatty acid-binding protein, brain, Brain lipid-binding protein, BLBP, Brain-type fatty acid-binding protein, B-FABP, Fatty acid-binding protein 7, Mammary-derived growth inhibitor related, FABP7, BLBP, FABPB, MRG|
|Target/Specificity||This FABP7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 104-132 amino acids from the C-terminal region of human FABP7.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||FABP7 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||BLBP, FABPB, MRG|
|Function||B-FABP could be involved in the transport of a so far unknown hydrophobic ligand with potential morphogenic activity during CNS development. It is required for the establishment of the radial glial fiber system in developing brain, a system that is necessary for the migration of immature neurons to establish cortical layers (By similarity).|
|Tissue Location||Expressed in brain and other neural tissues.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
FABP7 is a brain fatty acid binding protein. Fatty acid binding proteins (FABPs) are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. FABPs are thought to play roles in fatty acid uptake, transport, and metabolism.
Iwayama, Y., et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (2), 484-493 (2010)
Maekawa, M., et al. J. Hum. Genet. 55(2):127-130(2010)
Goto, Y., et al. J. Invest. Dermatol. 130(1):221-229(2010)
If you have any additional inquiries please email technical services at email@example.com.